A biotechnology company with a validated, innovative scientific platform manufactures a variety of generic drugs and focuses on developing novel therapeutics to treat rare, immune-mediated diseases. It has an extensive pipeline of drug candidates that target disease areas with significant unmet need in which the current standard of care falls short.
